These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 8255964
41. [Effect of elevated blood pressure and proteinuria on progression of mesangioproliferative glomerulonephritis]. Wiecek A, Strzelczyk P, Kokot F, Karkoszka H, Irzyniec T. Pol Arch Med Wewn; 1994 Oct; 92(4):331-7. PubMed ID: 7854961 [Abstract] [Full Text] [Related]
42. [The late results of treating membranous glomerulonephritis]. Belovezhdov N, Robeva R, Dimitrova V. Vutr Boles; 1990 Oct; 29(3):53-60. PubMed ID: 2284800 [Abstract] [Full Text] [Related]
43. Urinary glycosaminoglycan composition in chronic glomerulonephritis. De Muro P, Faedda R, Satta A, Finetti D, Masala A, Cigni A, Sanna GM, Cherchi GM. J Nephrol; 2005 Oct; 18(2):154-60. PubMed ID: 15931643 [Abstract] [Full Text] [Related]
44. Long-term outcome of adult patients with minimal urinary abnormalities and normal renal function. Shu KH, Ho WL, Lu YS, Cheng CH, Wu MJ, Lian JD. Clin Nephrol; 1999 Jul; 52(1):5-9. PubMed ID: 10442489 [Abstract] [Full Text] [Related]
45. Does renal function improve after diagnosis of malignant phase hypertension? Lip GY, Beevers M, Beevers DG. J Hypertens; 1997 Nov; 15(11):1309-15. PubMed ID: 9383181 [Abstract] [Full Text] [Related]
46. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy. Bazzi C, Usui T, Rizza V, Casellato D, Gallieni M, Nangaku M. Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902 [Abstract] [Full Text] [Related]
47. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Morales JM, Pascual-Capdevila J, Campistol JM, Fernandez-Zatarain G, Muñoz MA, Andres A, Praga M, Martinez MA, Usera G, Fuertes A, Oppenheimer F, Artal P, Darnell A, Rodicio JL. Transplantation; 1997 Jun 15; 63(11):1634-9. PubMed ID: 9197359 [Abstract] [Full Text] [Related]
48. "Benign" hypertensive nephrosclerosis. Dasgupta I, Porter C, Innes A, Burden R. QJM; 2007 Feb 15; 100(2):113-9. PubMed ID: 17244670 [Abstract] [Full Text] [Related]
50. Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis? Davenport A, Maciver AG, Hall CL, MacKenzie JC. Clin Nephrol; 1994 May 15; 41(5):271-6. PubMed ID: 8050206 [Abstract] [Full Text] [Related]
51. Immunosuppression can arrest progressive renal failure due to idiopathic membranous glomerulonephritis. Williams PS, Bone JM. Nephrol Dial Transplant; 1989 May 15; 4(3):181-6. PubMed ID: 2498775 [Abstract] [Full Text] [Related]
52. Clinicopathological features and prognosis of Kimura's disease with renal involvement in Chinese patients. Chen Y, Wang J, Xu F, Zeng C, Liu Z. Clin Nephrol; 2016 Jun 15; 85(6):332-9. PubMed ID: 27142199 [Abstract] [Full Text] [Related]
53. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis. Honkanen EO, Teppo AM, Grönhagen-Riska C. Kidney Int; 2000 Jun 15; 57(6):2343-9. PubMed ID: 10844604 [Abstract] [Full Text] [Related]
60. [Serum level and urinary excretion of RANTES in patients with primary glomerulonephritis]. Kacprzyk F. Pol Arch Med Wewn; 2002 Sep 15; 108(3):837-42. PubMed ID: 12600179 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]